Allan Nixon

Kiromic Submits IND to FDA for Allogeneic T-cell Therapy

NICE Recommends Keytruda for Metastatic MSI-High, Mismatch Repair-Deficient Colorectal Cancer

In Brief This Week: Merck, Sidney Kimmel Cancer Center, Seattle Cancer Care Alliance

Kinnate Biopharma Raises $35M to Establish Chinese Joint Venture

Merus Inks Partnerships in Israel, Italy, Spain to ID Patients for Bispecific Antibody Trial

Flare Therapeutics Launches With $82M in Series A Financing